Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ambea ABCHIX:AMBEAS 82 10-Year Share Buyback Ratio is -1.70 as of Jun. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr124.17 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 307 Healthcare Providers & Services companies, Ambea AB ranks better than 54.07% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Ambea AB's current 10-Year Share Buyback Ratio was -1.70%.
CHIX:AMBEAs's 10-Year Share Buyback Ratio is ranked better than 54.07% of 307
companies
in the Healthcare Providers & Services industry
Industry Median: -1.9
vs CHIX:AMBEAs: -1.70
Ambea AB (CHIX:AMBEAs) 10-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Ambea AB 10-Year Share Buyback Ratio Related Terms
CHIX:AMBEAS vs HCA, THC, DVA: 10-Year Share Buyback Ratio Comparison
For the Medical Care Facilities subindustry, Ambea AB's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB 10-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's 10-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Ambea AB's 10-Year Share Buyback Ratio falls into.
This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 10-Year Share Buyback Ratio of -1.70 mean?
Ambea AB (CHIX:AMBEAS) has a 10-Year Share Buyback Ratio of -1.70 as of Jun. 2026. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Ambea AB and its competitors. According to the industry distribution chart, Ambea AB ranks #141 out of 307 companies in the Healthcare Providers & Services industry, placing it in the top 45.9%.
Is Ambea AB's 10-Year Share Buyback Ratio too high?
Ambea AB's current 10-Year Share Buyback Ratio is -1.70. Based on the distribution chart, Ambea AB ranks #141 out of 307 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's 10-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #141 out of 307 companies for 10-Year Share Buyback Ratio. This puts Ambea AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 10-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 10-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year Share Buyback Ratio mean?
A high 10-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. View historical data for Ambea AB and its competitors. Ambea AB's current 10-Year Share Buyback Ratio is -1.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr124.17, compared to a current price of kr144.20 — trading 16.1% above its estimated fair value. The current 10-Year Share Buyback Ratio is -1.70. Ambea AB's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year Share Buyback Ratio calculated?
10-Year Share Buyback Ratio is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current 10-Year Share Buyback Ratio is -1.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 16.1% above its estimated GF Value™ of kr124.17.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
10-Year Share Buyback Ratio: -1.70
GF Value™: kr124.17 vs. price of kr144.20 (16.1% above fair value)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score
Get the complete analysis for CHIX:AMBEAS
10-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
